ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,851Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 288

$1.06M Total Retail Price of All Prescriptions

Rank: 2 out of 288

481 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 481 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 17,475 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 978 961 1 2
SIMVASTATIN 691 655 2 1
AMLODIPINE BESYLATE 542 520 3 6
OMEPRAZOLE 503 478 4 3
HYDROCODONE-ACETAMINOPHEN 384 324 S3 5 7
FUROSEMIDE 373 357 6 5
WARFARIN SODIUM 355 353 7 9
POTASSIUM CHLORIDE 332 320 8 11
MELOXICAM 326 309 9 44
ATENOLOL 322 317 10 10
METOPROLOL SUCCINATE 305 285 11 15
GLIMEPIRIDE 302 271 12 32
DONEPEZIL HCL 298 298 13 29
METOPROLOL TARTRATE 294 258 14 8
ATORVASTATIN CALCIUM 293 277 15 14
TRAMADOL HCL 278 265 16 19
CITALOPRAM HBR 231 211 17 18
DIOVAN 230 225 18 53
HYDROCHLOROTHIAZIDE 223 220 19 13
NAMENDA 215 215 20 39
CARVEDILOL 208 204 21 27
PANTOPRAZOLE SODIUM 206 199 22 42
SERTRALINE HCL 204 199 23 25
CRESTOR 202 159 24 26
METFORMIN HCL 199 170 25 12
METFORMIN HCL ER 198 179 26 76
PRAMIPEXOLE DIHYDROCHLORIDE 198 182 26 122
LOSARTAN-HYDROCHLOROTHIAZIDE 191 172 28 55
ALLOPURINOL 174 172 29 23
LOSARTAN POTASSIUM 166 161 30 16
CYMBALTA 166 155 30 67
LANTUS 162 157 32 31
CARBIDOPA-LEVODOPA 149 149 33 72
ALENDRONATE SODIUM 148 146 34 20
ISOSORBIDE MONONITRATE ER 147 147 35 35
KLOR-CON M10 146 135 36 175
LISINOPRIL 137 109 37 4
TAMSULOSIN HCL 132 130 38 24
POLYETHYLENE GLYCOL 3350 132 125 38 38
NEXIUM 131 96 40 43
GABAPENTIN 130 95 41 17
ZOLPIDEM TARTRATE 128 114 42 22
TRIAMTERENE-HCTZ 126 126 43 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 109 44 34
DIVALPROEX SODIUM 119 119 45 207
AMIODARONE HCL 114 114 46 137
MIRTAZAPINE 114 114 46 60
BYSTOLIC 104 103 48 96
RISPERIDONE 98 98 49 98
PRAVASTATIN SODIUM 94 91 50 21
CIPROFLOXACIN HCL 93 85 51 62
SYNTHROID 91 91 52 63
ROPINIROLE HCL 91 76 52 74
DIOVAN HCT 87 68 54 112
OXYCODONE HCL 87 60 S2 54 127
AGGRENOX 85 82 56 136
MICARDIS 80 80 57 219
CLOPIDOGREL 79 74 58 47
TORSEMIDE 77 77 59 134
VESICARE 76 75 60 129
BENICAR HCT 76 76 60 172
ESCITALOPRAM OXALATE 73 70 62 87
ADVAIR DISKUS 69 53 63 50
LYRICA 69 63 63 114
SPIRONOLACTONE 68 64 65 36
EXFORGE 67 63 66 315
FENOFIBRATE 67 47 66 61
EXELON 66 66 68 185
SPIRIVA 64 57 69 48
LEVEMIR FLEXPEN 64 60 69 187
EVISTA 63 63 71 126
ALBUTEROL SULFATE 63 63 71 133
LEVETIRACETAM 62 62 73 125
BUMETANIDE 62 58 73 105
FLUTICASONE PROPIONATE 61 51 75 41
MICARDIS HCT 61 61 75 324
FINASTERIDE 59 59 77 82
DILTIAZEM ER 59 59 77 102
PLAVIX 59 54 77 71
LIPITOR 56 54 80 107
AMITRIPTYLINE HCL 56 56 R 80 65
SYMBICORT 55 55 82 104
DIGOXIN 55 55 82 51
ACTOS 53 53 84 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.